HOME >> BIOLOGY >> NEWS
Plant-Based Therapies Examined For Colon Cancer Prevention

ve for foods in the United States. Quercetin can be naturally found in most fruits and vegetables, such as cranberries and onions, as well as tea. Quercetin, when digested in the colon, breaks down into rutin. Many colorectal cancers begin as noncancerous growths, called polyps, in the mucosal lining of the colon and rectum, the last part of the digestive tract. An inherited defective gene can cause some forms of the disease, but not all. The polyps develop because the normal routine of cell division and apoptosis goes awry. When apoptosis is disabled, tissues that rely on it no longer have a way to regulate their cell populations and cancer may ensue.

In the study, Shiff and fellow researchers will examine the influence of administering different amounts of either curcumin, rutin or quercetin on the amount of colorectal cells replaced and the speed of this process during the normal functions of the intestine. The study includes looking for and measuring the size and kind of any intestinal polyps that develop in the participants.

"Ideally, we would like to find the lowest, optimal dose of each of the three plant compounds that would safely inhibit the development of colorectal cancer," explains Shiff.

The study lasts for up to 10 weeks. During the first two weeks, participants eat a controlled diet so that initial information can be collected. In the following weeks, the investigators randomly assign the participants to continue on the initial diet alone or a diet supplemented with one of the plant phenolic compounds or sulindac, the NSAID. During this second phase, participants stay for an additional four or eight weeks.

For the study, the research team will recruit men and women aged 18 years and older who have a history of colon polyps. Participants may not smoke and should be healthy. People interested in enrolling as participants should call Dawn Stoddard, M.S., F.N.P., at 1-212-327-7458
'"/>

Contact: Marion E. Glick or Joseph Bonner
runews@rockvax.rockefeller.edu
212-327-7900
Rockefeller University
24-Sep-1997


Page: 1 2 3

Related biology news :

1. Plant-Based Fat Inhibits Growth Of Breast-Cancer Cell Line, UB Researchers Show
2. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
3. Plant-Based Fat Inhibits Cancer-Cell Growth By Enhancing Cells Signaling System, UB Researchers Show
4. Image-guided Therapies
5. New Anti-HIV Therapies Needed To Eradicate HIV
6. UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level
7. Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies
8. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
9. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
10. Harvard Medical School Researchers Identify Four Human Genes Essential To Cell Division; Discovery Yields New Target For Cancer Therapies
11. Novel AIDS-Directed Technology: Approach Permits Optimization Of Existing Drug Therapies And Targeted, Patient-Specific Treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Plant Based Therapies Examined For Colon Cancer Prevention

(Date:5/20/2013)... new study conducted at the University of Bristol and ... Biology sheds light on how the brain and ... from Bristol,s School of Earth Sciences, together with Tom ... the brains of 150 million year old dinosaurs. , ... dinosaur Dysalotosaurus lettowvorbecki : a very young (juvenile) ...
(Date:5/19/2013)... engineered a strain of electricity-producing bacteria that can grow ... carbon dioxide as its sole source of carbon. ... findings at the 113th General Meeting of the American ... of current production solely on hydrogen," says Amit Kumar, ... co-authors are part of the Lovley Lab Group at ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
Breaking Biology News(10 mins):Fossil brain teaser 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: